NeoGenomics Laboratories

NeoGenomics operates a network of cancer-focused genetic testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, and other laboratories in the United States. It offers cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; immunohistochemistry and digital imaging testing services to localize proteins in cells of a tissue section, as well as to allow clients to see and utilize scanned slides, and perform quantitative analysis for various stains; and molecular testing services that focus on the analysis of DNA and RNA, and the structure and function of genes at the molecular level.
Company Growth (employees)
Type
Public
HQ
Fort Myers, US
Founded
2002
Size (employees)
938 (est)
NeoGenomics Laboratories was founded in 2002 and is headquartered in Fort Myers, US

NeoGenomics Laboratories Office Locations

NeoGenomics Laboratories has offices in Fort Myers, Nashville, Tampa, Irvine and in 1 other location
Fort Myers, US (HQ)
9 12701 Commonwealth Dr
Fresno, US
400 30 River Park Pl W
Irvine, US
100 5 Jenner
Nashville, US
20 618 Grassmere Park
Tampa, US
228 10002 Princess Palm Ave
Show all (5)

NeoGenomics Laboratories Financials and Metrics

NeoGenomics Laboratories Financials

NeoGenomics Laboratories's revenue was reported to be $244.1 m in FY, 2016
USD

Revenue (Q2, 2017)

66.1 m

Gross profit (Q2, 2017)

31.2 m

Gross profit margin (Q2, 2017), %

47%

Net income (Q2, 2017)

(43 k)

EBIT (Q2, 2017)

1.3 m

Market capitalization (16-Feb-2018)

226.9 m

Cash (30-Jun-2017)

10.9 m
NeoGenomics Laboratories's current market capitalization is $226.9 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

66.5 m87.1 m99.8 m244.1 m

Revenue growth, %

31%15%145%

Cost of goods sold

34.7 m46.4 m56 m133.7 m

Gross profit

31.7 m40.7 m43.8 m110.4 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

16.9 m18.2 m20.7 m23.2 m23 m24.4 m25.1 m59.7 m63.1 m60.8 m61.7 m66.1 m

Cost of goods sold

8.7 m9.5 m10.4 m12.9 m13.5 m13.6 m14 m32.5 m34.5 m33.4 m34.5 m34.9 m

Gross profit

8.2 m8.7 m10.2 m10.3 m9.5 m10.8 m11.2 m27.2 m28.6 m27.3 m27.2 m31.2 m

Gross profit Margin, %

48%48%50%44%41%44%44%46%45%45%44%47%
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

4.8 m33.7 m23.4 m12.5 m

Accounts Receivable

18.7 m20.5 m48.9 m55.5 m

Inventories

2.3 m2.6 m5.1 m6.3 m

Current Assets

27.5 m58.7 m99 m78.8 m
USDQ3, 2013Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

4.9 m33 m34 m19.3 m21.8 m28.9 m11 m10.9 m

Accounts Receivable

15.7 m21.1 m21.6 m50.1 m53.5 m50.2 m61.7 m61.8 m

Inventories

2.1 m3.4 m3 m5.3 m5.5 m6 m6 m5.5 m

Current Assets

23.8 m59.6 m60.9 m81.2 m87.5 m92.6 m84.6 m83.4 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

2 m1.1 m(2.5 m)(5.7 m)

Depreciation and Amortization

4.2 m7.1 m23.2 m

Inventories

(229 k)(896 k)(1.1 m)

Cash From Operating Activities

2.2 m9.5 m6.4 m21.5 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Net Income

1.2 m102 k376 k85 k(761 k)(937 k)(1.1 m)155 k568 k500 k(654 k)(697 k)

Depreciation and Amortization

3.1 m1.2 m2.4 m3.9 m5.6 m11 m17 m5.7 m11.4 m

Inventories

21 k(800 k)(351 k)(437 k)(844 k)

Accounts Payable

(1.1 m)(41 k)2 k
USDY, 2017

Revenue/Employee

70.5 k

Financial Leverage

2 x
Show all financial metrics

NeoGenomics Laboratories Market Value History

NeoGenomics Laboratories's Web-traffic and Trends

NeoGenomics Laboratories Online and Social Media Presence

NeoGenomics Laboratories Company Life and Culture

You may also be interested in